NCT07101029

Brief Summary

To compare the effect of Bio-C Temp Bioceramic intracanal dressing versus calcium hydroxide as intracanal medicaments on:

  • Intensity of postoperative pain
  • levels of MMP -9 in Periapical Fluids.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P50-P75 for early_phase_1

Timeline
2mo left

Started Aug 2025

Shorter than P25 for early_phase_1

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Aug 2025Jul 2026

First Submitted

Initial submission to the registry

July 25, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

11 months

First QC Date

July 25, 2025

Last Update Submit

July 28, 2025

Conditions

Keywords

Bio-C TempCalcium HydroxideIntracanal medicamentMatrix Metalloproteinase 9BiomarkersPost operative pain

Outcome Measures

Primary Outcomes (8)

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    6 hours post-instrumentation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    12 hours post-instrumentation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    24 hours post-instrumentation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    48 hours post-instrumentation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    6 hours post-obturation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    12 hours post-obturation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    24 hours post-obturation

  • Intensity of post-operative pain

    Intensity of post-operative pain as measured by Numerical Rating Scale (NRS)

    48 hours post-obturation

Secondary Outcomes (2)

  • Periapical MMP-9 level

    at the first visit post- instrumentation

  • Periapical MMP-9 Level

    After 1 week at the second visit (pre-obturation)

Study Arms (2)

Bio-C Temp

EXPERIMENTAL

This group will Receive Bio-C Temp Bioceramic paste as intracanal dressing

Drug: Bio-C Temp Intracanal Medication

Calcium Hydroxide

ACTIVE COMPARATOR

This group will Receive Calcium Hydroxide paste as intracanal dressing

Drug: Calcium Hydroxide Intracanal medication

Interventions

Bio-C Temp Bioceramic intracanal dressing in the form of injectable premixed paste

Also known as: Bioceramic intracanal dressing
Bio-C Temp

Calcium Hydroxide intracanal dressing in the form of injectable premixed paste

Calcium Hydroxide

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-50 years old.
  • Males and females.
  • Healthy patients categorized as I or II according to The American Society of Anesthesiologists.
  • (ASA I or II), with no underlying allergies.
  • Single-rooted mandibular premolar teeth, having single root canal:
  • Diagnosed clinically with pulp necrosis.
  • Absence of spontaneous pulpal pain.
  • Slight widening in the periodontal membrane space or with periapical radiolucency not exceeding 2\*2 mm radiographically.
  • Patients accepting to participate in the trial.
  • Patients who can understand pain scale and can sign the informed consent

You may not qualify if:

  • Medically compromised patients having significant systemic disorders (ASA III or IV).
  • Pregnant females.
  • If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively as it might alter their pain perception.
  • Teeth with multiple canals. 9
  • Teeth that show association with acute periapical abscess, swelling or fistulous tract.
  • Teeth with vital pulp.
  • Non-restorable teeth or teeth that could not be adequately isolated with a rubber dam.
  • Immature teeth.
  • Teeth with greater than grade I mobility or pocket depth greater than 4 mm.
  • Teeth showing radiographic evidence of external or internal root resorption, vertical root fracture, perforation or calcification.
  • Patients with two or more adjacent teeth requiring endodontic treatment.
  • Patients reporting bruxism, clenching or TMJ problems.
  • Inability to perceive the given instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Periapical PeriodontitisPain, Postoperative

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitisPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant Lecturer

Study Record Dates

First Submitted

July 25, 2025

First Posted

August 3, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

August 3, 2025

Record last verified: 2025-07